Back

Gene-specific risk models in genetic dilated cardiomyopathy for implantable cardioverter defibrillator decisions: a critical perspective on limitations and applicability

29 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies Risk Factors and Risk Assessment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Amelie Beblo

Charite University Hospital, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
Myocardial fibrosis predicts sudden cardiac death in patients with hypertrophic cardiomyopathy after cardiac electronic device implantation: a retrospective study
Doctor X. Lian (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Late gadolinium enhancement and ventricular arrhythmias in patients with dilated cardiomyopathy: a systematic review and meta-analysis
Ms S. Mahmud (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Cohort analysis of variants in the RBM20 gene. Is there a profile for electrocardiographic phenotype, arrhythmogenic features and outcomes?
Doctor M. Pagotti (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Genetic defects in young out-of-hospital cardiac arrest (OHCA) patients in our city: the GenetiCA study
Doctor E. Baldi (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Myocarditis complicated by ventricular tachycardia: prevalence, outcomes and acute ablation results
Associate Professor E. Leshem (Hadera, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction and management of ventricular arrhythmias in non-ischaemic cardiomyopathies

The Event

Event poster

ESC Congress 2025

29 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
A patient with dilated cardiomyopathy, mildly reduced ejection fraction and left ventricular scarring: how to implement the guidelines and take-home messages
thumbnail
Congress Presentation
Predicting risk and guiding therapy in biventricular/left-dominant arrhythmogenic cardiomyopathy
thumbnail
Congress Presentation
Dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources